ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Feb 14, 2007 Elite Pharmaceuticals Appoints Chief Scientific Officer

Dec 20, 2006 Elite Pharmaceuticals and ECR Launch Second Once-Daily Antihistamine LODRANE 24D®,Second Product Utilizing Elite's Drug Delivery Technology

Dec 13, 2006 Elite Pharmaceuticals Appoints a Prominent Specialty Pharmaceutical Executive, Dr. Veerappan Subramanian, to its Board of Directors and Engages Dr. Subramanian as Strategic Advisor

Nov 30, 2006 ELITE TO PRESENT AT BANK OF MONTREAL'S 2006 FOCUS ON HEALTHCARE CONFERENCE ON DECEMBER 7, 2006

Oct 27, 2006 ELITE HOLDS CLINICAL GUIDANCE MEETING WITH THE FDA ON ITS ABUSE DETERRENT PAIN PROGRAM

Sep 12, 2006 Elite Pharmaceuticals Provides Update on Company's Progress and Projected Milestones

Sep 06, 2006 Elite Pharmaceuticals Receives Approval from Independent Review Board to initiate Phase II Clinical Trial for Abuse Resistant Drug Product

Aug 31, 2006 ELITE TO PARTICIPATE IN ROTH CAPITAL'S 2006 NEW YORK CONFERENCE

Aug 16, 2006 Elite Pharmaceuticals is in Compliance with AMEX Requirements

Jun 27, 2006 Elite Pharmaceuticals Successfully Concludes Second Pilot Phase I Trial of its Once-Daily Oxycodone Hydrochloride Product

16 17 18 19 20 21 22 23 24 25

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.